Wong et al. stratified MAF populations in terms of their expression of Thy1, smooth muscle actin (SMA), and FAP markers and demonstrated in pre-treatment melanoma specimens that MAF profiles are associated with melanoma immunotherapy outcome. The gene discussed is THY1; the disease is melanoma.